Carbosilane dendrimers: Drug and gene delivery applications

[1]  J. Zoller.  dendrimers , 2020, Catalysis from A to Z.

[2]  E. Pędziwiatr-Werbicka,et al.  Dendrimers and hyperbranched structures for biomedical applications , 2019, European Polymer Journal.

[3]  J. Lazniewska,et al.  Cytotoxicity of Dendrimers , 2019, Biomolecules.

[4]  T. Weil,et al.  Patchy Amphiphilic Dendrimers Bind Adenovirus and Control Its Host Interactions and in Vivo Distribution , 2019, ACS nano.

[5]  Hong Cai,et al.  Induction of memory-like dendritic cell responses in vivo , 2019, Nature Communications.

[6]  Xiangrong Song,et al.  Clinical translation of gene medicine , 2019, The journal of gene medicine.

[7]  Arash Salmaninejad,et al.  Tumor-associated macrophages: role in cancer development and therapeutic implications , 2019, Cellular Oncology.

[8]  B. Aderibigbe,et al.  Application of Dendrimers for the Treatment of Infectious Diseases , 2018, Molecules.

[9]  V. Dzmitruk,et al.  Dendrimers Show Promise for siRNA and microRNA Therapeutics , 2018, Pharmaceutics.

[10]  Sarwar Hossen,et al.  Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review , 2018, Journal of advanced research.

[11]  I. Franiak-Pietryga,et al.  Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer , 2018 .

[12]  S. Mukherji,et al.  Dendrimer as a multifunctional capping agent for metal nanoparticles for use in bioimaging, drug delivery and sensor applications. , 2018, Journal of materials chemistry. B.

[13]  F. González-Nilo,et al.  Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion. , 2018, Bioconjugate chemistry.

[14]  Xiangyang Shi,et al.  Dendrimers in combination with natural products and analogues as anti-cancer agents. , 2018, Chemical Society reviews.

[15]  R. Sader,et al.  Tumor-associated Macrophages, Angiogenesis, and Tumor Cell Migration in Oral Squamous Cell Carcinoma , 2017, Annals of African medicine.

[16]  R. Gómez,et al.  Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection. , 2017, European journal of pharmacology.

[17]  R. Sader,et al.  Evaluation of Tumour Associated Macrophages and Angiogenesis in Ameloblastoma. , 2017, Journal of clinical and diagnostic research : JCDR.

[18]  Thavendran Govender,et al.  The role of nanotechnology in the treatment of viral infections , 2017, Therapeutic advances in infectious disease.

[19]  A. Seifalian,et al.  Will Nanotechnology Bring New Hope for Gene Delivery? , 2017, Trends in biotechnology.

[20]  Rishi Paliwal,et al.  Transdermal Drug Delivery: Opportunities and Challenges for Controlled Delivery of Therapeutic Agents Using Nanocarriers. , 2017, Current drug metabolism.

[21]  M. Malý,et al.  Phosphonium carbosilane dendrimers for biomedical applications – synthesis, characterization and cytotoxicity evaluation , 2017 .

[22]  M. Ionov,et al.  Ruthenium metallodendrimers with anticancer potential in an acute promyelocytic leukemia cell line (HL60) , 2017 .

[23]  Rafael Gómez,et al.  Effect of Several HIV Antigens Simultaneously Loaded with G2-NN16 Carbosilane Dendrimer in the Cell Uptake and Functionality of Human Dendritic Cells. , 2016, Bioconjugate chemistry.

[24]  R. Gómez,et al.  Synthesis of degradable cationic carbosilane dendrimers based on Si–O or ester bonds , 2016 .

[25]  M. Malý,et al.  Proof of concept of a “greener” protein purification/enrichment method based on carboxylate-terminated carbosilane dendrimer-protein interactions , 2016, Analytical and Bioanalytical Chemistry.

[26]  R. Reguera,et al.  Improved Efficiency of Ibuprofen by Cationic Carbosilane Dendritic Conjugates. , 2016, Molecular pharmaceutics.

[27]  Henner Hollert,et al.  Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. , 2016, Toxicology and applied pharmacology.

[28]  A. Masotti,et al.  Regulation of angiogenesis through the efficient delivery of microRNAs into endothelial cells using polyamine-coated carbon nanotubes , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[29]  Tairong Kuang,et al.  Recent Progress in Dendrimer-based Gene Delivery Systems , 2016 .

[30]  Maribella Domenech,et al.  Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds? , 2016, Tissue engineering. Part B, Reviews.

[31]  M. Malý,et al.  Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action , 2016, International journal of nanomedicine.

[32]  I. Bravo-Osuna,et al.  Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration. , 2016, Molecular pharmaceutics.

[33]  B. Worley,et al.  Structure-activity characterization of nitric oxide-releasing dendrimers as dual-action antibacterial agents , 2016 .

[34]  Rafael Gómez,et al.  Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1 , 2016, International journal of nanomedicine.

[35]  D. Scheinberg,et al.  Targeted fibrillar nanocarbon RNAi treatment of acute kidney injury , 2016, Science Translational Medicine.

[36]  Michael R Hamblin,et al.  Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. , 2016, Chemical Society reviews.

[37]  Sanjeev Banerjee,et al.  PAMAM dendrimers as promising nanocarriers for RNAi therapeutics , 2015 .

[38]  M. Vallet‐Regí,et al.  Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers. , 2015, Chemistry.

[39]  S. Álvarez,et al.  Fluorescein labelled cationic carbosilane dendritic systems for biological studies , 2015 .

[40]  Koldo Urbiola,et al.  Nanoparticulated Polymeric Systems for Gene Delivery. , 2015, Current pharmaceutical design.

[41]  N. Taveira,et al.  Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides. , 2015, Nanoscale.

[42]  R. Gómez,et al.  Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[43]  M. J. Serramía,et al.  Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[44]  C. Kojima,et al.  Dendrimers for theranostic applications , 2015, Biomolecular concepts.

[45]  A. Venyaminova,et al.  Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction. , 2015, International journal of pharmaceutics.

[46]  K. Miłowska,et al.  Carbosilane dendrimers inhibit α-synuclein fibrillation and prevent cells from rotenone-induced damage. , 2015, International journal of pharmaceutics.

[47]  F. Van de Werf,et al.  Evolving therapies for myocardial ischemia/reperfusion injury. , 2015, Journal of the American College of Cardiology.

[48]  Rafael Gómez,et al.  Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission. , 2015, Nanomedicine.

[49]  T. Hianik,et al.  Dendrimers complexed with HIV-1 peptides interact with liposomes and lipid monolayers. , 2015, Biochimica et biophysica acta.

[50]  S. Álvarez,et al.  In vivo delivery of siRNA to the brain by carbosilane dendrimer. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[51]  Á. Corbí,et al.  Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions. , 2015, Nanoscale.

[52]  Ramon Eritja,et al.  Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides. , 2015, International journal of pharmaceutics.

[53]  JiménezJos Luis,et al.  Antiviral Action of Sulfonate Anionic Carbosilane Dendrimer as a Topical Microbicide against HIV Infection , 2014 .

[54]  Toshinori Sato,et al.  Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding Peptide. , 2014, Journal of medicinal chemistry.

[55]  R. Gómez,et al.  Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides , 2014, International journal of nanomedicine.

[56]  Á. Corbí,et al.  Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[57]  Morteza Milani,et al.  Dendrimers: synthesis, applications, and properties , 2014, Nanoscale Research Letters.

[58]  M. Malý,et al.  Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour. , 2014, Organic & biomolecular chemistry.

[59]  R. Gómez,et al.  Synthesis of anionic carbosilane dendrimers via “click chemistry” and their antiviral properties against HIV , 2014 .

[60]  F. Albericio,et al.  Amphiphilic cationic carbosilane-PEG dendrimers: synthesis and applications in gene therapy. , 2014, European journal of medicinal chemistry.

[61]  M. Leal,et al.  Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[62]  Leyuan Xu,et al.  Dendrimer advances for the central nervous system delivery of therapeutics. , 2014, ACS chemical neuroscience.

[63]  D. Appelhans,et al.  Biophysical characterization of glycodendrimers as nano-carriers for HIV peptides. , 2013, Current medicinal chemistry.

[64]  S. Gopal,et al.  Dendrimer a new dimension in targeting biofilms. , 2013, Mini-Reviews in Medical Chemistry.

[65]  M. J. Serramía,et al.  Cationic Carbosilane Dendrimers as Non‐viral Vectors of Nucleic Acids (Oligonucleotide or siRNA) for Gene Therapy Purposes , 2013 .

[66]  L. Pérez-Alvárez,et al.  Development of sulphated and naphthylsulphonated carbosilane dendrimers as topical microbicides to prevent HIV-1 sexual transmission , 2013, AIDS.

[67]  F. J. de la Mata,et al.  Thiol-Ene Synthesis of Cationic Carbosilane Dendrons: a New Family of Synthons , 2013 .

[68]  A. Caminade,et al.  Validation of a generation 4 phosphorus-containing polycationic dendrimer for gene delivery against HIV-1. , 2012, Current Medicinal Chemistry.

[69]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[70]  A. Kakkar,et al.  Dendrimers as bactericides , 2012 .

[71]  A. El Kadib,et al.  Biological properties of new viologen-phosphorus dendrimers. , 2012, Molecular pharmaceutics.

[72]  C. Tros de Ilarduya,et al.  Synthesis of cationic carbosilane dendrimers via click chemistry and their use as effective carriers for DNA transfection into cancerous cells. , 2012, Molecular pharmaceutics.

[73]  Jiahai Zhang,et al.  Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity , 2011, International journal of nanomedicine.

[74]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as nanocarriers. , 2011, Chemical communications.

[75]  S. Beg,et al.  Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. , 2011, CNS & neurological disorders drug targets.

[76]  P. Ortega,et al.  Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1. , 2011, Colloids and surfaces. B, Biointerfaces.

[77]  Felipe García,et al.  Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer. , 2010, Biomaterials.

[78]  P. Ortega,et al.  Carbosilane Dendrimers to Transfect Human Astrocytes with Small Interfering RNA Targeting Human Immunodeficiency Virus , 2010, BioDrugs.

[79]  A. Salgado,et al.  Dendrimers and derivatives as a potential therapeutic tool in regenerative medicine strategies—A review , 2010 .

[80]  B. Nanjwade,et al.  Dendrimers: emerging polymers for drug-delivery systems. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[81]  A. Caminade,et al.  Phosphonate terminated PPH dendrimers: influence of pendant alkyl chains on the in vitro anti-HIV-1 properties. , 2009, Organic & biomolecular chemistry.

[82]  Yasuo Suzuki,et al.  Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses. , 2009, Bioorganic & medicinal chemistry.

[83]  Shaker A Mousa,et al.  Emerging nanopharmaceuticals. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[84]  P. Ortega,et al.  Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[85]  P. Allavena,et al.  The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.

[86]  Kato L. Killops,et al.  Robust, efficient, and orthogonal synthesis of dendrimers via thiol-ene "click" chemistry. , 2008, Journal of the American Chemical Society.

[87]  T. Xu,et al.  Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. , 2007, Current drug discovery technologies.

[88]  Dirk Nagorsen,et al.  Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival , 2007, Journal of Translational Medicine.

[89]  Clara Viñas,et al.  Modular Construction of Neutral and Anionic Carboranyl-Containing Carbosilane-Based Dendrimers , 2007 .

[90]  L. Corey.  Synergistic copathogens--HIV-1 and HSV-2. , 2007, The New England journal of medicine.

[91]  P. Heegaard,et al.  Dendrimer based anti-infective and anti-inflammatory drugs. , 2006, Recent patents on anti-infective drug discovery.

[92]  Deanna Cross,et al.  Gene therapy for cancer treatment: past, present and future. , 2006, Clinical medicine & research.

[93]  M. J. Serramía,et al.  Novel Water-Soluble Carbosilane Dendrimers: Synthesis and Biocompatibility , 2006 .

[94]  C. Schengrund,et al.  Dendrimers and antivirals: a review. , 2005, Current drug targets. Infectious disorders.

[95]  A. Palucka,et al.  Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.

[96]  A. Caminade,et al.  Phosphorus dendrimers: from synthesis to applications , 2003 .

[97]  F. Diederich,et al.  Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery. , 2003, Angewandte Chemie.

[98]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[99]  Toru Watanabe,et al.  Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. , 2002, Anticancer research.

[100]  J. Fréchet,et al.  Convergent dendrons and dendrimers: from synthesis to applications. , 2001, Chemical reviews.

[101]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[102]  F. Vögtle,et al.  Dendrimers: From Design to Application-A Progress Report. , 1999, Angewandte Chemie.

[103]  Jonathan M. Austyn,et al.  Dendritic cells , 1998, Current opinion in hematology.

[104]  R. Mülhaupt,et al.  A mesogen‐functionized carbosilane dendrimer: A dendritic liquid crystalline polymer , 1996 .

[105]  P. Hodge.  Polymer science branches out , 1993, Nature.

[106]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[107]  T. Tsumuraya,et al.  General strategy for the systematic synthesis of oligosiloxanes. Silicone dendrimers , 1990 .

[108]  N. Niles.  Pathologic Basis of Disease , 1974 .

[109]  A. Caminade,et al.  Phosphorus Dendrimers as Vectors for Gene Therapy in Cancer , 2018 .

[110]  U. H. Sk.  Nanosize Dendrimers: Potential Use as Carriers and Antimicrobials , 2017 .

[111]  R. Gómez,et al.  Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[112]  A. Pêgo,et al.  Delivering siRNA with Dendrimers: In Vivo Applications. , 2017, Current gene therapy.

[113]  K. Jain.  Dendrimers: Smart nanoengineered polymers for bioinspired applications in drug delivery , 2017 .

[114]  R. Gómez,et al.  Nanotech-derived topical microbicides for HIV prevention: the road to clinical development. , 2015, Antiviral research.

[115]  Barbara Klajnert,et al.  Complexation of HIV derived peptides with carbosilane dendrimers. , 2013, Colloids and surfaces. B, Biointerfaces.

[116]  V. Dzmitruk,et al.  Dendrimers in Anti-HIV Therapy , 2011 .

[117]  J. Reek,et al.  Catalysis in the core of a carbosilane dendrimer , 1999 .

[118]  J. S. Choi,et al.  Poly(ethylene glycol)-block-poly(L-lysine) dendrimer: novel linear polymer/dendrimer block copolymer forming a spherical water-soluble polyionic complex with DNA. , 1999, Bioconjugate chemistry.

[119]  P. Costa.  Robbins' pathologic basis of disease. R. S. Cotran, V. Kumar and S. L. Robbins. W. B. Saunders, Philadelphia, 1989. No. of pages: 1519. Price £37. ISBN:0 7216 2302 6 , 1990 .